Promentis Pharmaceuticals, Inc.
Total Funding
$29 Million
Total Rounds
2
First Raise
Jan 22, 2014
Latest Raise
Mar 30, 2017
Organization Chart
Founders and leadership hierarchy for this company.
Contact details require Sales or Enterprise
All Funding Rounds
Showing 1 of 2 rounds
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 3/30/2017 | Series C | $26 Million | OrbiMed, F-Prime Capital Partners, Aisling Capital |
1 more funding round available
Upgrade to Premium to view all historical funding rounds
Company Performance Metrics
Premium Feature
Upgrade to Premium to view Capital Momentum Score and performance metrics